Koyfin Home > Directory > Health Care > Intellia Thera CS > Cash and Short-Term Investments

Intellia Thera CS Cash and Short-Term Investments Chart (NTLA)

Intellia Thera CS annual/quarterly Cash and Short-Term Investments from 2014 to 2020.
  • Intellia Thera CS Cash and Short-Term Investments for the quarter ending September 09, 2020 was $408m a 31.43% increase of 128m year over year
  • Intellia Thera CS Cash and Short-Term Investments for the last 12 months ending September 09, 2020 was $408m a 31.43% increase of 128m year over year
  • Intellia Thera CS Annual Cash and Short-Term Investments for 2019 was $280m a -12.27% decrease of -34m from 2018
  • Intellia Thera CS Annual Cash and Short-Term Investments for 2018 was $314m a -8.48% decrease of -27m from 2017
  • Intellia Thera CS Annual Cash and Short-Term Investments for 2017 was $341m a 19.85% increase of 68m from 2016
Other Balance Sheet Metrics:
  • Intellia Thera CS Total Assets for the quarter ending September 09, 2018 was $321m a -17.12% decrease of -55m year over year
  • Intellia Thera CS Other Liabilities for the quarter ending September 09, 2018 was $32m a -38.16% decrease of -12m year over year
  • Intellia Thera CS Total Equity for the quarter ending September 09, 2018 was $263m a -14.18% decrease of -37m year over year
View Chart On Koyfin

Quarterly NTLA Cash and Short-Term Investments Data

09/2020$408m
06/2020$437m
03/2020$250m
12/2019$280m
09/2019$286m
06/2019$271m
03/2019$297m
12/2018$314m
09/2018$293m
06/2018$306m

Annual NTLA Cash and Short-Term Investments Data

2019$280m
2018$314m
2017$341m
2016$273m
2015$76m
2014$10m